Organo Corp.
14.50
USD
+10.45
(+258.02%)
Organo Corp.
OTC:ORCRY
(OTC Markets)
Recent
price
14.50
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.- Similar Companies
- Business
- Organo Corporation (6368.T) engages primarily in water treatment engineering and functional products businesses, designing, constructing, and maintaining water purification systems for industrial, municipal, and specialized applications worldwide. The company offers an extensive portfolio of core products and services, including pure water systems such as reverse osmosis (RO) systems, regenerative automatic and manual pure water systems, electric regeneration pure water systems, desktop-type and cabinet-type pure water systems, electrodeionization high-purity water systems, and two-stage RO systems; ultrapure water systems comprising desktop and cabinet-type ultrapure water systems and final polishing units; other equipment like alkaline electrolyzed water production equipment, homogenizers, electro conductivity meters, resistivity meters, ion exchange filters, and marine scrubber wastewater treatment systems; water, wastewater, and RO water treatment chemicals; industrial filters including micro filters, sanitary filters, polypropylene filters, plastic housings, RO wound cartridges, PF cartridges, capsule filters, and PF carbon filters; and commercial water purifiers. For specific industries, Organo provides ultrapure and multi-functional water production systems, wastewater treatment systems, valuable resource recovery systems for hydrofluoric acid, tetramethylammonium hydroxide (TMAH), and rare metals, and organic solvent refining systems tailored to electronics; purified water production and supply systems, ultrafiltration (UF) water systems, water for injection systems, and pharmaceutical water consulting for pharmaceuticals, cosmetics, and medical devices; condensate filters, demineralizers, reactor water cleanup, fuel pool cleanup, makeup water, and wastewater treatment for energy and power generation; as well as sugar refining systems and equipment for food processing. Founded in 1946 and headquartered in Tokyo, Japan, Organo Corporation operates across Japan, Taiwan, China, Southeast Asia, and other international markets, serving sectors such as semiconductors, flat panel displays, pharmaceuticals, power generation, water supply, sewage treatment, and sugar production with comprehensive in-house capabilities spanning product development, design, construction, sales, and after-sales service. The company maintains research and development centers, factories, and sales offices to support its global footprint and positions itself as a one-stop solution provider for ultrapure water, pure water, industrial wastewater, sewerage, and resource recovery needs. In recent developments, Organo Corporation announced organizational restructuring and changes in officers during 2025, alongside releasing financial results and notices for shareholder meetings, reflecting ongoing efforts to adapt its structure amid evolving water treatment demands. The company continues to invest in technologies for resource recovery and membrane separation, including expansions in ultrapure water systems for semiconductor fabs with a U.S. presence established in 2021, while maintaining focus on sustainable practices in response to global water scarcity and stricter regulations. No major acquisitions, funding rounds, or new product launches were reported in the past 1-2 years, with operations emphasizing steady innovation in existing segments.